Gilead Sciences
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Phone: (650) 574-3000Website: https://www.gilead.com/Careers: www.gilead.com/careersPatient Assistance Program: www.gilead.com/purpose/medication-access
Latest news
- FDA Expands Indication for Gilead's Vemlidy (tenofovir alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
28 March 2024 - U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy to Treat People with HIV with Suppressed Viral Loads, Pre-Existing Resistance
26 February 2024 - FDA Approves Veklury (remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment
24 August 2023 - FDA Approves Veklury (remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
14 July 2023 - Hepcludex (bulevirtide) Demonstrates Sustained Efficacy and Safety Profile in People With Chronic Hepatitis Delta Virus at 96 Weeks
23 June 2023 - FDA Approves Sunlenca (lenacapavir) Twice-Yearly Treatment for People Living With Multi-Drug Resistant HIV
22 December 2022 - U.S. Food and Drug Administration Approves Vemlidy (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients
2 November 2022 - Gilead Receives Complete Response Letter from U.S. FDA for Bulevirtide for the Treatment of Adults with Hepatitis Delta Virus
27 October 2022 - WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
16 September 2022 - Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor
27 June 2022
Drugs Associated with Gilead Sciences, Inc.
Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
Atripla
Generic name: efavirenz/emtricitabine/tenofovir Drug class: antiviral combinations |
99 reviews | 9.1 / 10 |
Biktarvy
Generic name: bictegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
180 reviews | 7.1 / 10 |
Cayston
Generic name: aztreonam Drug class: miscellaneous antibiotics |
||
Complera
Generic name: emtricitabine/rilpivirine/tenofovir Drug class: antiviral combinations |
53 reviews | 8.3 / 10 |
Descovy
Generic name: emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
15 reviews | 6.9 / 10 |
Emtriva
Generic name: emtricitabine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
Epclusa
Generic name: sofosbuvir/velpatasvir Drug class: antiviral combinations |
304 reviews | 7.7 / 10 |
Genvoya
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
117 reviews | 7.3 / 10 |
Harvoni
Generic name: ledipasvir/sofosbuvir Drug class: antiviral combinations |
338 reviews | 8.6 / 10 |
Hepsera
Generic name: adefovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
Letairis
Generic name: ambrisentan Drug class: agents for pulmonary hypertension |
10 reviews | 8.9 / 10 |
Lexiscan
Generic name: regadenoson Drug class: cardiac stressing agents |
30 reviews | 5.3 / 10 |
Odefsey
Generic name: emtricitabine/rilpivirine/tenofovir alafenamide Drug class: antiviral combinations |
10 reviews | 8.4 / 10 |
Ranexa
Generic name: ranolazine Drug class: antianginal agents |
62 reviews | 7.1 / 10 |
Sovaldi
Generic name: sofosbuvir Drug class: miscellaneous antivirals |
42 reviews | 7.7 / 10 |
Stribild
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir Drug class: antiviral combinations |
81 reviews | 9.5 / 10 |
Sunlenca
Generic name: lenacapavir Drug class: miscellaneous antivirals |
||
Tamiflu
Generic name: oseltamivir Drug class: neuraminidase inhibitors |
521 reviews | 6.0 / 10 |
Tecartus
Generic name: brexucabtagene autoleucel Drug class: miscellaneous antineoplastics |
||
Truvada
Generic name: emtricitabine/tenofovir Drug class: antiviral combinations |
31 reviews | 6.2 / 10 |
Tybost
Generic name: cobicistat Drug class: antiviral boosters |
||
Veklury
Generic name: remdesivir Drug class: purine nucleosides |
||
Vemlidy
Generic name: tenofovir alafenamide Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
1 review | 8.0 / 10 |
Viread
Generic name: tenofovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
10 reviews | 8.0 / 10 |
Vosevi
Generic name: sofosbuvir/velpatasvir/voxilaprevir Drug class: antiviral combinations |
2 reviews | 10 / 10 |
Yescarta
Generic name: axicabtagene ciloleucel Drug class: miscellaneous antineoplastics |
||
Zydelig
Generic name: idelalisib Drug class: PI3K inhibitors |
2 reviews | 4.5 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
Discontinued Drugs
Brand/Generic Name | Reviews | Rating |
---|---|---|
Macugen
Generic name: pegaptanib Drug class: anti-angiogenic ophthalmic agents |
1 review | 9.0 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |